Sector ratings WuXi Biologics (Cayman) Inc. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 03:59:59 2026-06-12 pm EDT			5-day change	1st Jan Change
7.890 ^USD	+2.33%		-3.55%	-1.38%

Jun. 05	Wuxi Biologics Completes Topping Out of Drug Product Facility At Singapore Crdmo Hub	CI
May. 31	Wuxi Biologics adds 69 projects in Jan-April, maintains expected revenue growth	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility
ARGENX SE	56.42B		A
WUXI APPTEC CO., LTD.	44.54B		AAA
BIONTECH SE	22.9B	-	-	-		-
INSMED INCORPORATED	21.21B	-	A	-		-
GENMAB A/S	15.4B		A
EXELIXIS, INC.	13.35B		BB
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	12.36B	-	AA	-		-
PHARMAESSENTIA CORPORATION	11.15B		AA
MADRIGAL PHARMACEUTICALS, INC.	11.08B	-	B	-		-
SUMMIT THERAPEUTICS INC.	10.87B	-	-	-		-
AKESO, INC.	10.82B		B
ARROWHEAD PHARMACEUTICALS, INC.	10.5B	-	BB	-		-
NUVALENT, INC.	9.74B	-	CCC	-		-
CYTOKINETICS, INCORPORATED	9.52B	-	AA	-		-
REMEGEN CO., LTD.	7.93B		-
IMMUNITYBIO, INC.	7.44B	-	CCC	-		-
SAMSUNG EPIS HOLDINGS CO., LTD.	7.33B		AA				-
BIOCON LIMITED	7.13B		B
SPYRE THERAPEUTICS, INC.	7.02B	-	BB	-	-	-
Average	15.62B		BBB
Weighted average by Cap.			BBB